Recent research evaluated by the National Institutes of Health (NIH) suggests a connection between exposure to certain environmental chemicals and a specific form of breast cancer.

Key Takeaways

  • Research suggests that elevated blood plasma levels of two common per- and polyfluoroalkyl substances (PFAS)—specifically PFOA and PFOS—are associated with a higher incidence of estrogen receptor-negative (ER-negative) breast cancer.
  • The NIH study observed no clear link between these two chemicals and overall breast cancer risk.
  • ER-negative tumors do not use the hormone estrogen to grow, tend to be more aggressive, and currently have few established risk factors.

What the Source Says

In an analysis reported in the Journal of Clinical Oncology, NIH researchers examined data from the Sister Study, which originally enrolled 50,884 women aged 35 to 74 across the United States and Puerto Rico from 2003 to 2009. Scientists evaluated 17 different PFAS in blood samples collected years before diagnosis, comparing 1,609 women who developed breast cancer with a comparison group of 2,269 women.

Women with the highest blood levels of PFOA had a 67% higher rate of ER-negative breast cancer compared to those with the lowest levels. For PFOS, the rate was 93% higher. Often called "forever chemicals," PFAS are widely used in consumer products and remain in the environment and human body for years. Study leaders Alexandra White, Ph.D., and Che-Jung Chang, Ph.D., alongside HHS Secretary Robert F. Kennedy, Jr., indicated that the findings warrant further investigation into environmental health factors. Because ER-negative tumors lack hormone receptors, researchers suggest non-hormonal mechanisms, such as immune system alterations or changes in gene activity, might be involved, though this study did not directly test those biological pathways.

Practical Notes

Although legacy compounds like PFOA and PFOS have been largely phased out, they have been replaced by newer PFAS variants. Specific guidelines on how individuals can test or lower their personal exposure, as well as the health risks of replacement compounds, were not specified in the source; please check the official notice.

You should talk to your doctor about your overall risk factors, wellness routine, and any questions regarding regular health screenings.

🩺 Read the Original Source

Source: NIH News Releases · Published November 05, 2026 · Photo by Robert Laursoo on Unsplash

This article is for general information only and is not medical advice. Talk to your doctor before making health decisions.

Related Articles

Target leans into a growing food trend for the holidaysTarget leans into a growing food trend for the holidaysSupplySide Global 2026: Nexira spotlights women’s health, sports performance & GLP-1 nutritionSupplySide Global 2026: Nexira spotlights women’s health, sports pe...Shanthi Johnson receives national honour for advancing healthy agingShanthi Johnson receives national honour for advancing healthy agingNew health risk warning for anyone using almond, soy or oat milkNew health risk warning for anyone using almond, soy or oat milk